PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
•2.1 Preface
•2.2 Preface
•2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE
•Market ecosystem
•Market characteristics
•Market segmentation analysis
•Value Chain Analysis

PART 04: MARKET SIZING
•Market definition
•Market sizing 2019
•Market size and forecast 2019-2024
•Market Outlook

PART 05: FIVE FORCES ANALYSIS
•Bargaining power of buyers
•Bargaining power of suppliers
•Threat of new entrants
•Threat of substitutes
•Threat of rivalry
•Market condition

PART 06: MARKET SEGMENTATION BY TECHNOLOGY
•Market segmentation by technology
•Comparison by technology
•Immunoassays - Market size and forecast 2019-2024
•Next generation sequencing - Market size and forecast 2019-2024
•Polymerase chain reaction - Market size and forecast 2019-2024
•In-situ hybridization - Market size and forecast 2019-2024
•Market opportunity by technology

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
•Geographic segmentation
•Geographic comparison
•North America - Market size and forecast 2019-2024
•Europe - Market size and forecast 2019-2024
•Asia - Market size and forecast 2019-2024
•ROW - Market size and forecast 2019-2024
•Key leading countries
•Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
•Market drivers
•Market challenges

PART 11: MARKET TRENDS
•Increasing cancer research and funding
•Increasing adoption of personalized medicine
•Growing importance of genomics in therapeutics

PART 12: VENDOR LANDSCAPE
•Overview
•Landscape disruption
•Competitive scenario

PART 13: VENDOR ANALYSIS
•Vendors covered
•Vendor classification
•Market positioning of vendors
•Abbott Laboratories
•Agilent Technologies Inc.
•Becton, Dickinson and Co.
•bioMérieux SA
•Bio-Rad Laboratories Inc.
•F. Hoffmann-La Roche Ltd.
•Illumina Inc.
•QIAGEN NV
•Siemens Healthineers AG
•Thermo Fisher Scientific Inc.

PART 14: APPENDIX
•Research methodology
•List of abbreviations
•Definition of market positioning of vendors
Exhibit 01: Vendor: Key offerings
Exhibit 02: Global healthcare technology market
Exhibit 03: Segments of global healthcare technology market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Technology - Market share 2019-2024 (%)
Exhibit 19: Comparison by technology
Exhibit 20: Immunoassays - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Immunoassays - Year-over-year growth 2020-2024 (%)
Exhibit 22: Next generation sequencing - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Next generation sequencing - Year-over-year growth 2020-2024 (%)
Exhibit 24: Polymerase chain reaction - Market size and forecast 2019-2024 ($ millions)
Exhibit 25: Polymerase chain reaction - Year-over-year growth 2020-2024 (%)
Exhibit 26: In-situ hybridization - Market size and forecast 2019-2024 ($ millions)
Exhibit 27: In-situ hybridization - Year-over-year growth 2020-2024 (%)
Exhibit 28: Market opportunity by technology
Exhibit 29: Customer landscape
Exhibit 30: Market share by geography 2019-2024 (%)
Exhibit 31: Geographic comparison
Exhibit 32: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: North America - Year-over-year growth 2020-2024 (%)
Exhibit 34: Top 3 countries in North America
Exhibit 35: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 36: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 37: Top 3 countries in Europe
Exhibit 38: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 39: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 40: Top 3 countries in Asia
Exhibit 41: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 42: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 43: Top 3 countries in ROW
Exhibit 44: Key leading countries
Exhibit 45: Market opportunity
Exhibit 46: Impact of drivers and challenges
Exhibit 47: Vendor landscape
Exhibit 48: Landscape disruption
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Abbott Laboratories - Vendor overview
Exhibit 53: Abbott Laboratories - Business segments
Exhibit 54: Abbott Laboratories - Organizational developments
Exhibit 55: Abbott Laboratories - Geographic focus
Exhibit 56: Abbott Laboratories - Segment focus
Exhibit 57: Abbott Laboratories - Key offerings
Exhibit 58: Abbott Laboratories - Key customers
Exhibit 59: Agilent Technologies Inc. - Vendor overview
Exhibit 60: Agilent Technologies Inc. - Product segments
Exhibit 61: Agilent Technologies Inc. - Organizational developments
Exhibit 62: Agilent Technologies Inc. - Geographic focus
Exhibit 63: Agilent Technologies Inc. - Segment focus
Exhibit 64: Agilent Technologies Inc. - Key offerings
Exhibit 65: Agilent Technologies Inc. - Key customers
Exhibit 66: Becton, Dickinson and Co. - Vendor overview
Exhibit 67: Becton, Dickinson and Co. - Business segments
Exhibit 68: Becton, Dickinson and Co. - Organizational developments
Exhibit 69: Becton, Dickinson and Co. - Geographic focus
Exhibit 70: Becton, Dickinson and Co. - Segment focus
Exhibit 71: Becton, Dickinson and Co. - Key offerings
Exhibit 72: Becton, Dickinson and Co. - Key customers
Exhibit 73: bioMérieux SA - Vendor overview
Exhibit 74: bioMérieux SA - Product segments
Exhibit 75: bioMérieux SA - Organizational developments
Exhibit 76: bioMérieux SA - Geographic focus
Exhibit 77: bioMérieux SA - Key offerings
Exhibit 78: bioMérieux SA - Key customers
Exhibit 79: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 80: Bio-Rad Laboratories Inc. - Business segments
Exhibit 81: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 82: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 83: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 84: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 85: Bio-Rad Laboratories Inc. - Key customers
Exhibit 86: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 87: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 88: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 89: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 90: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 91: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 92: F. Hoffmann-La Roche Ltd. - Key customers
Exhibit 93: Illumina Inc. - Vendor overview
Exhibit 94: Illumina Inc. - Business segments
Exhibit 95: Illumina Inc. - Organizational developments
Exhibit 96: Illumina Inc. - Geographic focus
Exhibit 97: Illumina Inc. - Segment focus
Exhibit 98: Illumina Inc. - Key offerings
Exhibit 99: Illumina Inc. - Key customers
Exhibit 100: QIAGEN NV - Vendor overview
Exhibit 101: QIAGEN NV - Product segments
Exhibit 102: QIAGEN NV - Organizational developments
Exhibit 103: QIAGEN NV - Geographic focus
Exhibit 104: QIAGEN NV - Segment focus
Exhibit 105: QIAGEN NV - Key offerings
Exhibit 106: QIAGEN NV - Key customers
Exhibit 107: Siemens Healthineers AG - Vendor overview
Exhibit 108: Siemens Healthineers AG - Business segments
Exhibit 109: Siemens Healthineers AG - Organizational developments
Exhibit 110: Siemens Healthineers AG - Geographic focus
Exhibit 111: Siemens Healthineers AG - Segment focus
Exhibit 112: Siemens Healthineers AG - Key offerings
Exhibit 113: Siemens Healthineers AG - Key customers
Exhibit 114: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 115: Thermo Fisher Scientific Inc. - Business segments
Exhibit 116: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 117: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 118: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 119: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 120: Thermo Fisher Scientific Inc. - Key customers
Exhibit 121: Validation techniques employed for market sizing
Exhibit 122: Definition of market positioning of vendors

Companies Mentioned
. Abbott Laboratories
. Agilent Technologies Inc.
. Becton
. Dickinson and Co.
. bioMérieux SA
. Bio-Rad Laboratories Inc.
. F. Hoffmann-La Roche Ltd.
. Illumina Inc.
. QIAGEN NV
. Siemens Healthineers AG
. Thermo Fisher Scientific Inc.